Skip to main content

Advertisement

Log in

Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Cardiac involvement is the most important prognostic factor in eosinophilic granulomatosis with polyangiitis (EGPA, Churg–Strauss syndrome). The aims of this study were to describe findings of cardiac magnetic resonance (CMR) in patients with active EGPA and to find factors associated with cardiac involvement detected by CMR that could help identify patients who would benefit from the examination. Medical records and CMR images in 16 consecutive EGPA patients (8 women and 8 men, median age of 47 years ranging from 34 to 68 years) were reviewed. Clinical features and results of laboratory tests were compared according to the presence of myocardial late gadolinium enhancement (LGE) on CMR images. The patients were followed for the development of cardiac symptoms and signs (mean follow up duration, 40.5 ± 12.8 months). Among the total of 16 patients, 8 (50 %) had myocardial LGE according to CMR, located in the subendocardial layer in 7 of them (87.5 %). The extent of LGE had a significant negative correlation with left ventricular ejection fraction (LVEF, ρ = −0.723, p = 0.043). The presence of LGE was associated with larger end-systolic left ventricle internal dimension (34 vs. 28 mm, p = 0.027) and presence of diastolic dysfunction (75 vs. 0 %, p = 0.008) on echocardiography, elevated NT-proBNP (75 vs. 12.5 %, p = 0.012), and elevated CK-MB (62.5 vs. 0 %, p = 0.010) compared to the group without LGE. Only one patient (6.3 %) had cardiac symptoms before CMR and another patient (6.3 %) developed heart failure 4 years later during remission. The other 14 patients remained free from cardiac signs and symptoms during the follow-up period. In patients with active EGPA, CMR enables detection of cardiac involvement when cardiac symptoms are not present. Echocardiographic diastolic dysfunction and elevated NT-proBNP or CK-MB may help identify active EGPA patients who can benefit from CMR to detect cardiac involvement without cardiac symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27(2):277–301

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Gibelin A, Maldini C, Mahr A (2011) Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32(3):264–273

    Article  PubMed  Google Scholar 

  3. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337(21):1512–1523

    Article  CAS  PubMed  Google Scholar 

  4. Lanham JG, Elkon KB, Pusey CD et al (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore) 63(2):65–81

    Article  CAS  Google Scholar 

  5. Guillevin L, Cohen P, Gayraud M et al (1999) Churg–Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78(1):26–37

    Article  CAS  Google Scholar 

  6. Ramakrishna G, Midthun DE (2001) Churg–Strauss syndrome. Ann Allergy Asthma Immunol 86(6):603–613 (quiz 613)

    Article  CAS  PubMed  Google Scholar 

  7. Moosig F, Bremer JP, Hellmich B et al (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72(6):1011–1017

    Article  PubMed  Google Scholar 

  8. Dennert RM, van Paassen P, Schalla S et al (2010) Cardiac involvement in Churg–Strauss syndrome. Arthritis Rheum 62(2):627–634

    PubMed  Google Scholar 

  9. Neumann T, Manger B, Schmid M et al (2009) Cardiac involvement in Churg–Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 88(4):236–243

    Article  Google Scholar 

  10. Motwani M, Kidambi A, Greenwood JP et al (2014) Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies. Heart 100(21):1722–1733

    Article  PubMed  Google Scholar 

  11. Patel MR, Cawley PJ, Heitner JF et al (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120(20):1969–1977

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yoshida A, Ishibashi-Ueda H, Yamada N et al (2013) Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur J Heart Fail 15(2):166–175

    Article  PubMed  Google Scholar 

  13. Kassi M, Nabi F (2013) Role of cardiac MRI in the assessment of nonischemic cardiomyopathies. Methodist Debakey Cardiovasc J 9(3):149–155

    Article  PubMed  PubMed Central  Google Scholar 

  14. Neilan TG, Coelho-Filho OR, Danik SB et al (2013) CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6(9):944–954

    Article  PubMed  PubMed Central  Google Scholar 

  15. Marmursztejn J, Guillevin L, Trebossen R et al (2013) Churg–Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford) 52(4):642–650

    Article  CAS  Google Scholar 

  16. Mavrogeni S, Karabela G, Gialafos E et al (2013) Cardiac involvement in ANCA (+) and ANCA (−) Churg–Strauss syndrome evaluated by cardiovascular magnetic resonance. Inflamm Allergy Drug Targets 12(5):322–327

    Article  CAS  PubMed  Google Scholar 

  17. Szczeklik W, Miszalski-Jamka T, Mastalerz L et al (2011) Multimodality assessment of cardiac involvement in Churg–Strauss syndrome patients in clinical remission. Circ J 75(3):649–655

    Article  PubMed  Google Scholar 

  18. Wassmuth R, Gobel U, Natusch A et al (2008) Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg–Strauss syndrome. J Card Fail 14(10):856–860

    Article  PubMed  Google Scholar 

  19. Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100

    Article  CAS  PubMed  Google Scholar 

  20. Flossmann O, Bacon P, de Groot K et al (2007) Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66(3):283–292

    PubMed  Google Scholar 

  21. Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542

    Article  PubMed  Google Scholar 

  22. Picard MH, Adams D, Bierig SM et al (2011) American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr 24(1):1–10

    Article  PubMed  Google Scholar 

  23. Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107–133

    Article  PubMed  Google Scholar 

  24. Chuang ML, Gona P, Hautvast GL et al (2014) CMR reference values for left ventricular volumes, mass, and ejection fraction using computer-aided analysis: the Framingham Heart Study. J Magn Reson Imaging 39(4):895–900

    Article  PubMed  Google Scholar 

  25. Bhagirath KM, Paulson K, Ahmadie R et al (2009) Clinical utility of cardiac magnetic resonance imaging in Churg–Strauss syndrome: case report and review of the literature. Rheumatol Int 29(4):445–449

    Article  PubMed  Google Scholar 

  26. Marmursztejn J, Vignaux O, Cohen P et al (2009) Impact of cardiac magnetic resonance imaging for assessment of Churg–Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 27(1 Suppl 52):S70–S76

    CAS  PubMed  Google Scholar 

  27. Mahrholdt H, Wagner A, Judd RM et al (2002) Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 23(8):602–619

    Article  CAS  PubMed  Google Scholar 

  28. Hundley WG, Bluemke DA, Finn JP et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121(22):2462–2508

    Article  PubMed  Google Scholar 

  29. Cummings KW, Bhalla S, Javidan-Nejad C et al (2009) A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 29(1):89–103

    Article  PubMed  Google Scholar 

  30. Pela G, Tirabassi G, Pattoneri P et al (2006) Cardiac involvement in the Churg–Strauss syndrome. Am J Cardiol 97(10):1519–1524

    Article  PubMed  Google Scholar 

  31. Morgan JM, Raposo L, Gibson DG (1989) Cardiac involvement in Churg–Strauss syndrome shown by echocardiography. Br Heart J 62(6):462–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Devereux RB, Hawkins I, Kramer-Fox R et al (1986) Complications of mitral valve prolapse. Disproportionate occurrence in men and older patients. Am J Med 81(5):751–758

    Article  CAS  PubMed  Google Scholar 

  33. Kuznetsova T, Herbots L, Lopez B et al (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2(2):105–112

    Article  PubMed  Google Scholar 

  34. Lin YC, Oliveira GH, Villa-Forte A (2013) Churg–Strauss syndrome and persistent heart failure: Active disease or damage? J Clin Rheumatol 19(7):390–392 (discussion 419)

    Article  PubMed  Google Scholar 

  35. Sinico RA, Di Toma L, Maggiore U et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndrome. Arthritis Rheum 52(9):2926–2935

    Article  CAS  PubMed  Google Scholar 

  36. Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109(10):1250–1258

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Dong-Chull Choi or Yeon Hyeon Choe.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yune, S., Choi, DC., Lee, BJ. et al. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis. Int J Cardiovasc Imaging 32 (Suppl 1), 155–162 (2016). https://doi.org/10.1007/s10554-016-0843-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-016-0843-y

Keywords

Navigation